<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link href="style.css" rel="stylesheet" type="text/css" />
<title>Lili Qin Research</title>
</head>

<body>
<div id="head-bar">
    <div id="head">
        <div id="logo"><a href="index.html">LILI Qin</a></div>
        <div id="description">M.D.,Ph.D.</div>
    </div>
</div>

<div id="menu-bar">
    <div id="menu">
        <ul id="menu-left">
            <li><a href="index.html">Home<span>Frontpage</span></a></li>
            <li><a href="resume.html">Resume<span>Biography</span></a></li>
            <li><a href="research.html">Research<span>Experience</span></a></li>
            <li><a href="http://www.liliqin.com/articles/">Artilces<span>Interests</span></a></li>
        </ul>
        <ul id="menu-right">
            <li><a href="gallery.html">Gallery<span>Photos</span></a></li>
            <li><a href="contact.html">Contact<span>Address</span></a></li>
        </ul>
    </div>
</div>
<div id="main">
    <div id="content">
        <table width="100%" border="0" align="center" cellpadding="4" cellspacing="4" bgcolor="#333333">
            <tr>
                <td width="10" bgcolor="#ffffff">&nbsp;</td>
                <td><strong><font color="#cccccc">Research Projects</font></strong></td>
                <td width="160">&nbsp;</td>
            </tr>
        </table>
        <table width="100%" border="0" align="center" cellpadding="4" cellspacing="4">
            <tr>
                <td valign="top"><br />
                    <P><strong>In the Ph.D. program,  Lili Qin participated in two research projects.  In an 
                            immunological project, she prepared the polyclonal and monoclonal antibodies  against 
                            human cardiac troponin-I (cTn-I) by herself and assisted in developing the enzyme-linked  
                            immunosorbent assay which could be used in routine clinical test of myocardial infarction 
                            (MI). Her dissertation focused on the molecular mechanism  through which Aurora-A, an 
                            oncogenic protein, promotes tumorigenesis. In this  project, they screened the downstream 
                            targets of Aurora-A, and then  concentrated on how Aurora-A  regulates Cyclin B1. Some 
                            of the results have  been published in <em>Cancer Letters</em>.</strong></P>
                    <P><strong>Please find a brief description of that work here.</strong></P>
                    <HR />

                    <p><strong>The molecular mechanism of Aurora-A in tumorigenesis, 2006.3-2008.9</strong><br />
                        State Key Laboratory of Molecular Oncology (<a href="http://www.sklmo.org.cn/">SKLMO</a>), 
                        Cancer Institute &amp; Hospital (<a href="http://www.cicams.ac.cn/">CICAMS</a>), Chinese 
                        Academy of Medical Sciences and Peking Union  Medical College, Beijing China</p>
                    <p><strong>Summary:</strong> The  mitotic regulator Aurora-A is an oncogenic protein that is 
                        over-expressed in  many types of human tumors. This research focuses on the underlying 
                        mechanism  through which Aurora-A  promotes tumorigenesis. In Aim 1, we will screen the 
                        downstream targets of Aurora-A. We found that Aurora-A induces expression  changes of many
                        proteins implicated in signaling pathways of cell cycle control  and apoptosis. In Aim 2, 
                        we will concentrate on the molecular mechanism of Aurora-A in cell cycle  control and in 
                        tumorigenesis. We found that overexpression of Aurora-A causes an elevation of Cyclin B1  
                        expression. Cyclin B1 degradation is delayed in Aurora-A  over-expressing cells, which 
                        depends on Aurora-A  kinase activity. In contrast, Aurora-A RNAi enhances Cyclin B1 
                        degradation. Furthermore, we found that Aurora-A overexpression reduces the  interaction 
                        of Cyclin B1 with APC subunits.  In human esophageal squamous  cell carcinomas (ESCC), 
                        overexpression of Aurora-A  was correlated with deregulated expression of Cyclin B1. 
                        Taken together, these findings  suggest that overexpression of Aurora-A  may stabilize 
                        Cyclin B1 through inhibiting its Ubiquitin-mediated degradation. Meanwhile, we found 
                        that Aurora-A interacts with Cyclin B1. Then the  interaction domains and the role of 
                        Aurora-A  kinase activity in the interaction were investigated. These results may provide 
                        new insight into the mechanism of how  deregulated Aurora-A contributes to genomic 
                        instability and carcinogenesis.</p>
                    <p><strong>Skills and Abilities:</strong><br />
                        * Cell culture and treatment<br />
                        * Protein purification and analysis (SDS-PAGE; Western Blotting)<br />
                        * Immunological techniques (IF; IHC)<br />
                        * Protein-protein interaction (IP; Pull-down assay)<br />
                        * Preparation and analysis of RNA (PCR; RT-PCR; agarose gel  electrophoresis)<br />
                        * Recombinant DNA techniques (Preparation  of plasmid DNA; Mutagenesis of cloned DNA; 
                        Enzymatic manipulation of DNA; cDNA  cloning; Recombinant protein expression in 
                        <em>E. coli </em>and eukaryotic cells;  Transformation; Transfection)<br />
                        * Applications of computer (Primier5; SPSS; SigmaPlot; QuantityOne;  EndNote)</p>

                    <HR />

                    <p><strong>The Enzyme-Linked-Immunosorbent Assay for cardiac  troponin-I, 2004.9-2005.7</strong><br />
                        Institute of  Radiation Medicine, Chinese Academy  of Medical Sciences and Peking 
                        Union Medical  College (<a href="http://www.pumc.edu.cn/">PUMC</a>), Tianjin, China</p>
                    <p><strong>Summary:</strong> To improve the sensitivity  and specificity of biochemical 
                        markers of myocardial infarction (MI), monoclonal  antibodies against human cardiac 
                        troponin-I (cTn-I) are widely used to measure cTn-I  in serum. In this project, we 
                        prepared polyclonal and monoclonal antibodies and  developed the enzyme-linked 
                        immunosorbent  assay for  cTn-I measurement using  monoclonal antibody. The results 
                        proved to be appropriate for routine clinical test  and scientific research with 
                        broad application prospects.</p>
                    <p><strong>Skills and Abilities:</strong><br />
                        * Cell culture<br />
                        * Polypeptide synthesis<br />
                        * Animal manipulation; Antiserum generation and monoclonal antibody  isolation <br />
                        * Hybridoma technology<br />
                        * Protein  immunological assay (ELISA)<br />
                        * Protein  purification and analysis (SDS-PAGE)</p>
                    <p>&nbsp;</p>    </td>
            </tr>
        </table>
    </div>
</div>

<div id="foot-bar">
    <div id="foot">
        <div id="foot-note">Copyright 2008-2009, Lili Qin, All rights reserved.</div>
        <div id="counter">
            <!-- Start of StatCounter Code -->
            <script type="text/javascript">
                var sc_project=4672130; 
                var sc_invisible=0; 
                var sc_partition=46; 
                var sc_click_stat=1; 
                var sc_security="8b706415"; 
            </script>

            <script type="text/javascript"
            src="http://www.statcounter.com/counter/counter.js"></script>
            <noscript>
                <div class="statcounter">
                    <a title="counter" href="http://www.statcounter.com/" target="_blank">
                        <img class="statcounter"
                             src="http://c.statcounter.com/4672130/0/8b706415/0/"
                             alt="counter" ></a></div></noscript>
            <!-- End of StatCounter Code -->
        </div>
        <ul id="foot-menu">
            <li><a href="index.html">Home</a></li>
            <li><a href="resume.html">Resume</a></li>
            <li><a href="research.html">Research</a></li>
            <li><a href="http://www.liliqin.com/articles/">Articles</a></li>
            <li><a href="gallery.html">Gallery</a></li>
            <li><a href="contact.html">Contact</a></li>
        </ul>
    </div>
</div>
</body>
</html>
